The first EAGLE course on Evidence and Research in Rectal Cancer is based around different learning pathways:
- formal lectures for individuals to gain knowledge
- clinical cases for individuals to gain competence
- virtual classrooms with tutored learning for groups using clinical cases, with expert advice to gain competence and experience
- Examinations on the multidisciplinary treatment of rectal cancer are available and successful results lead to CME accreditation
EAGLE also offers the possibility of active case based learning with a flexibility in choice of learning strategies: trainees and specialists, wherever they are located:
- are able to opt for an individual approach at their own rhythm to test clinical cases or agenda (Thomas) and advice from experts 5Rome course)
- can chose to participate to virtual classroom sessions, in which they will be learning while interacting with other students and may go for virtual tutorials guided by coaches and experts
Who are the experts behind the first EAGLE course:
Director of the ESTRO course on Evidence and Research in Rectal Cancer and driving force behind the EAGLE e-learning course is Vincenzo Valentini, Radiation Oncologist at the Università Cattolica S.Cuore in Rome, Italy
The faculty of this multidisciplinary course includes experts from different disciplines such as:
- Regina Beets-Tan, Radiologist at the University Hospital of Maastricht in The Netherlands
- Josep Borras, Epidemiologist at Cancer Plan in the Department of Health of the Hospitalet de Llobregat in Barcelona, Spain
- Nigel Scott, Pathologist at St James¹s University Hospital in Leeds, UK
- Karin Haustermans, Radiation Oncologist at the University Hospital Gasthuisberg in Leuven, Belgium
- Jan Willem Leer, Radiation Oncologist at the Radboud University Nijmegen Medical Center in Nijmegen, The Netherlands
- Connie Marijnen, Radiation Oncologist at the National Cancer Institute in Amsterdam, The Netherlands
- Claus Rödel, Radiation Oncologist at the University Hospital Frankfurt in Germany
- Zoran Krivokapic, Surgeon at the Institute for Digestive Diseases of the Clinical Center of Serbia in Belgrade, Serbia
- Lars Pahlman, Surgeon at the Uppsala University Hospital in Sweden
- Cornelius Van de Velde, Surgeon at the Leiden University Medical Center in The Netherlands
- Hans Joachim Schmoll, Medical Oncologist at the Martin Luther University Halle-Wittenberg in Halle, Germany


